Page last updated: 2024-08-24

lamivudine and Atypical Mycobacterial Infection, Disseminated

lamivudine has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bachmeyer, C; Benchaa, B; Blum, L; Danne, O; Gruat, N; Stelianides, S1

Other Studies

1 other study(ies) available for lamivudine and Atypical Mycobacterial Infection, Disseminated

ArticleYear
Mycobacterium xenopi pulmonary infection in an HIV infected patient under highly active antiretroviral treatment.
    Sexually transmitted infections, 2002, Volume: 78, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Combinations; Female; Humans; Immunocompromised Host; Lamivudine; Lung Diseases; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine

2002